NO137782C - Analogifremgangsmaate for fremstilling av nye farmakologisk aktive amino-fenyl-etanolaminer - Google Patents

Analogifremgangsmaate for fremstilling av nye farmakologisk aktive amino-fenyl-etanolaminer

Info

Publication number
NO137782C
NO137782C NO4814/73A NO481473A NO137782C NO 137782 C NO137782 C NO 137782C NO 4814/73 A NO4814/73 A NO 4814/73A NO 481473 A NO481473 A NO 481473A NO 137782 C NO137782 C NO 137782C
Authority
NO
Norway
Prior art keywords
ethanolamines
phenyl
preparation
active amino
pharmacological active
Prior art date
Application number
NO4814/73A
Other languages
English (en)
Norwegian (no)
Other versions
NO137782B (no
Inventor
Guenther Engelhardt
Johannes Keck
Gerd Krueger
Klaus-Reinhold Noll
Helmut Pieper
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2261914A external-priority patent/DE2261914C3/de
Priority claimed from DE19732345442 external-priority patent/DE2345442C2/de
Priority claimed from DE19732351281 external-priority patent/DE2351281C3/de
Priority claimed from DE2354961A external-priority patent/DE2354961C2/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO137782B publication Critical patent/NO137782B/no
Publication of NO137782C publication Critical patent/NO137782C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO4814/73A 1972-12-18 1973-12-17 Analogifremgangsmaate for fremstilling av nye farmakologisk aktive amino-fenyl-etanolaminer NO137782C (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE2261914A DE2261914C3 (de) 1972-12-18 1972-12-18 Amino-phenyl-äthanolamine und deren Säureadditionssalze, Verfahren zu deren Herstellung und Arzneimittel
DE19732345442 DE2345442C2 (de) 1973-09-08 1973-09-08 d- und l-Phenyläthanolamine und deren Salze, Herstellungsverfahren und Arzneimittel auf deren Basis
DE19732351281 DE2351281C3 (de) 1973-10-12 1973-10-12 Aminophenyl-äthanolamin-Derivate, deren Herstellung und Verwendung
DE2354961A DE2354961C2 (de) 1973-11-02 1973-11-02 Verfahren zur Herstellung von Aminophenyl-äthanolaminen

Publications (2)

Publication Number Publication Date
NO137782B NO137782B (no) 1978-01-16
NO137782C true NO137782C (no) 1978-04-26

Family

ID=27431596

Family Applications (1)

Application Number Title Priority Date Filing Date
NO4814/73A NO137782C (no) 1972-12-18 1973-12-17 Analogifremgangsmaate for fremstilling av nye farmakologisk aktive amino-fenyl-etanolaminer

Country Status (20)

Country Link
JP (1) JPS5811852B2 (fr)
KR (1) KR850001916B1 (fr)
BG (1) BG21209A3 (fr)
CA (1) CA1027955A (fr)
CH (2) CH605622A5 (fr)
DD (1) DD111574A5 (fr)
DK (1) DK150502C (fr)
FI (1) FI62052C (fr)
FR (1) FR2210414B1 (fr)
GB (1) GB1445740A (fr)
HK (1) HK6680A (fr)
HU (1) HU168701B (fr)
IE (1) IE39065B1 (fr)
IL (1) IL43837A (fr)
MY (1) MY8800145A (fr)
NL (1) NL176168C (fr)
NO (1) NO137782C (fr)
PL (1) PL97194B1 (fr)
RO (1) RO63025A (fr)
SE (1) SE409700B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430486A1 (fr) * 1978-07-07 1980-02-01 Oreal Conditionnement d'un produit desinfectant et desodorisant pour cuvette de toilettes
NL8105170A (nl) * 1980-12-10 1982-07-01 Thomae Gmbh Dr K Nieuwe fenylalkylaminen, werkwijze ter bereiding daarvan en de toepassing daarvan als geneesmiddelen.
FR2515177A1 (fr) * 1981-10-28 1983-04-29 Lafon Labor Nouveaux derives de 1-(aminophenyl)-2-amino-1-ethanol, leur procede de preparation et leur utilisation en therapeutique
GB8426191D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
US4943591A (en) * 1984-10-17 1990-07-24 Glaxo Group Limited Dichloroaniline derivatives
US4863959A (en) * 1985-10-17 1989-09-05 American Cyanamid Company Anthranilonitrile derivatives as useful agents for promoting growth, improving feed efficiency, and for increasing the lean meat to fat ratio of warm-blooded animals
ATE61794T1 (de) * 1985-10-17 1991-04-15 American Cyanamid Co Anthranilonitrilderivate und verwandte verbindungen als nuetzliche stoffe zur wachstumsbeschleunigung, zur verbesserung der futterqualitaet und zur steigerung des fleisch/fett-verhaeltnisses bei warmbluetigen tieren.
GB8603475D0 (en) * 1986-02-12 1986-03-19 Glaxo Group Ltd Chemical compounds
US4959381A (en) * 1987-02-10 1990-09-25 Glaxo Group Limited Pyridine compounds which have useful activity associated with reversible air ways obstruction
GB8703007D0 (en) * 1987-02-10 1987-03-18 Glaxo Group Ltd Chemical compounds
EP2423188B1 (fr) * 2003-08-29 2021-03-10 Mitsui Chemicals Agro, Inc. Produits intermédiaires pour la préparation d'insecticides agricoles et horticoles et leur procédé d'utilisation
GB0604822D0 (en) * 2006-03-09 2006-04-19 Arakis Ltd The treatment of inflammatory disorders and pain
CN100497296C (zh) * 2006-07-07 2009-06-10 沈阳药科大学 旋光活性的苯乙醇胺类化合物及其制法
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses

Also Published As

Publication number Publication date
HK6680A (en) 1980-03-07
RO63025A (fr) 1978-12-15
JPS4994640A (fr) 1974-09-09
GB1445740A (en) 1976-08-11
IE39065B1 (en) 1978-08-02
CA1027955A (fr) 1978-03-14
BG21209A3 (bg) 1976-03-20
DK150502B (da) 1987-03-16
NO137782B (no) 1978-01-16
NL176168B (nl) 1984-10-01
SE409700B (sv) 1979-09-03
IL43837A (en) 1977-02-28
KR830000207A (ko) 1983-03-30
AU6369373A (en) 1975-06-19
NL7316139A (fr) 1974-06-20
DD111574A5 (fr) 1975-02-20
HU168701B (fr) 1976-06-28
FR2210414A1 (fr) 1974-07-12
IL43837A0 (en) 1974-03-14
IE39065L (en) 1974-06-18
FI62052C (fi) 1982-11-10
CH605622A5 (fr) 1978-10-13
NL176168C (nl) 1985-03-01
FI62052B (fi) 1982-07-30
KR850001916B1 (ko) 1985-12-31
DK150502C (da) 1987-10-26
PL97194B1 (pl) 1978-02-28
CH614188A5 (en) 1979-11-15
MY8800145A (en) 1988-12-31
JPS5811852B2 (ja) 1983-03-04
FR2210414B1 (fr) 1977-01-28

Similar Documents

Publication Publication Date Title
NO140381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
NO137694C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
NO137782C (no) Analogifremgangsmaate for fremstilling av nye farmakologisk aktive amino-fenyl-etanolaminer
NO142033C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive isopropylamino-3-fenoksypropanoler
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO136360C (no) Analogifremgangsm}te for fremstilling av nye terapeutisk aktive 2-fenylamino-imidazolin-(2)-er
NO138599C (no) Analogifremgangsmaate til fremstilling av nye, terapeutisk virksomme tienopyrimidinderivater
NO138061C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive substituerte difenylpropionsyrederivater
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO140012C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av naftyridin
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO138025C (no) Analogifremgangsmaate til fremstilling av antimykotisk virksomme 1-etyl-imidazoler
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
NO138026C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner
NO141555C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk virksomme dibenzocykloheptenkarboksamider
NO136840C (no) Analogifremgangsm}te til fremstilling av nye, terapeutisk aktive derivater av isoindolin
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE403612B (sv) Analogiforfarande for framstellning av antibakteriellt aktiva hexametylen-bis-biguanider
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner